results
Last reviewed 01/2018
The incidence of the primary end point was:
- 9.6% in the angioplasty group
- 13.7% in the t-PA group
- odds ratio= 0.67 (95 percent confidence interval, 0.47 to 0.97; P = 0.033)
Death occurred in 5.7 percent of the patients assigned to angioplasty and 7.0 percent of those assigned to t-PA (P=0.37).
Reinfarction in 4.5 percent and 6.5 percent (P=0.13).
Disabling stroke in 0.2 percent and 0.9 percent (P=0.11).
The primary end point was observed in 10.6 percent of the patients in the angioplasty group assigned to heparin and 8.2 percent of those assigned to hirudin (P=0.37).
There was no significant difference in outcome at six months.